July 2, 2020
JPMA’s Drug Evaluation Committee Hiyoshi (left) and Vice Chair Kondo The COVID-19 pandemic has had a major impact on drug development. Clinical trial subjects refrain from visiting medical institutions, while drug makers have restricted the activities of their development staffers,...read more